Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Guggenheim Upgrades Immunovant to Buy

Guggenheim Upgrades Immunovant to Buy

Guggenheim analyst Yatin Suneja upgrades Immunovant (NASDAQ:IMVT) from Neutral to Buy.

byBenzinga Newsdesk

February 13, 2023

1 minute read

Guggenheim analyst Yatin Suneja upgrades Immunovant (NASDAQ:IMVT) from Neutral to Buy.

Callon Petroleum Company Announces Board Updates Including Appointment Of Matthew R. Bob As Chair

By Happy Mohamed

April 28, 7:13 AM

Callon Petroleum Company (NYSE:CPE) ("Callon" or the "Company") today announced that Matthew R. Bob has been named Chair of the Board of Directors and James ("Jim") Craddock

CPE

Alphabet To Rally Over 17%? Here Are 10 Other Analyst Forecasts For Wednesday

By Lisa Levin

July 5, 7:58 AM

Northland Capital Markets boosted the price target for Advanced Micro Devices, Inc. (NASDAQ: AMD) from $81 to $150. Northland Capital Markets analyst Gus Richard upgraded the stock from Market Perform to Outperform. AMD shares rose 1.7% to close at $115.82 on Monday.

AMD